Therapeutic innovation for multi-resistant candidemics: Synergy of isavuconazole and caspofungin association.

Candida Caspofungin Combined antifungal therapy Fungal infection Hematological patients Isavuconazole

Journal

Hematology reports
ISSN: 2038-8322
Titre abrégé: Hematol Rep
Pays: Switzerland
ID NLM: 101556723

Informations de publication

Date de publication:
26 Nov 2021
Historique:
received: 22 07 2021
accepted: 17 09 2021
entrez: 24 1 2022
pubmed: 25 1 2022
medline: 25 1 2022
Statut: epublish

Résumé

Fungal infections occurring in immunocompromised patients after immunochemotherapy treatment are often difficult to eradicate and capable of even being fatal. Systemic mycoses affecting severely immunocompromised patients often manifest acutely with rapidly progressive pneumonia, fungemia, or manifestations of extrapulmonary dissemination. Opportunistic fungal infections (mycoses) include several pathogens elements, as candidiasis, aspergillosis, mucormycosis (zygomycosis) and fusariosis. Prompt diagnosis and effective therapy are needed to improve the associated morbidity and mortality, especially in cases with non-canonical fungal localizations and not responsive to the available antifungal drugs.

Identifiants

pubmed: 35070221
doi: 10.4081/hr.2021.9329
pmc: PMC8743983
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9329

Informations de copyright

©Copyright: the Author(s).

Déclaration de conflit d'intérêts

Conflict of interest: The authors declare no potential conflict of interest.

Références

Pharmacotherapy. 2007 Dec;27(12):1711-21
pubmed: 18041891
J Ophthalmol. 2020 Oct 23;2020:8869590
pubmed: 33149945
Curr Eye Res. 2017 Feb;42(2):225-232
pubmed: 27348425
Ocul Immunol Inflamm. 2020 Apr 2;28(3):471-478
pubmed: 30810429
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038263
Am J Ophthalmol. 2012 Jan;153(1):162-6.e1
pubmed: 21917234
Klin Mikrobiol Infekc Lek. 2009 Apr;15(2):48-57
pubmed: 19488961
Med Mycol. 2021 Oct 4;59(10):1015-1023
pubmed: 34021571
Haematologica. 2012 Apr;97(4):560-7
pubmed: 22102706
Br J Ophthalmol. 2008 Apr;92(4):466-8
pubmed: 18369061

Auteurs

Andrea Duminuco (A)

Post Graduation School of Hematology, University of Catania, A.O.U. 'Policlinico-San Marco', Catania.

Elisa Mauro (E)

Division of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.

Giuseppe A M Palumbo (GAM)

Division of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.

Bruno Garibaldi (B)

Post Graduation School of Hematology, University of Catania, A.O.U. 'Policlinico-San Marco', Catania.

Marina Parisi (M)

Division of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.

Francesco Di Raimondo (F)

Division of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.

Cinzia Maugeri (C)

Division of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.

Calogero Vetro (C)

Division of Hematology, A.O.U. 'Policlinico-San Marco', Catania, Italy.

Classifications MeSH